Nalaganje...
The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia
A teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia was hospitalized and recovered in 15 days. The immunophenotyping analysis of peripheral blood cells was performed in two time points: the first was 1 month before (pre-infection) while the second was during COVID-19 pneumonia...
Shranjeno v:
| izdano v: | J Neuroimmunol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier B.V.
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361089/ https://ncbi.nlm.nih.gov/pubmed/32688146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jneuroim.2020.577323 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|